These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 11125950)
1. [Intraprostatic neuroendocrine system and glandular carcinogenesis]. Moretti C; Mencacci C; Frajese V; Frajese G Recenti Prog Med; 2000 Nov; 91(11):571-5. PubMed ID: 11125950 [No Abstract] [Full Text] [Related]
2. [Interleukin-6 implication in prostate cancer]. Cabrespine A; Bay JO; Verrelle P; Morel L Bull Cancer; 2007 Jul; 94(7 Suppl):F29-34. PubMed ID: 17845991 [TBL] [Abstract][Full Text] [Related]
3. Neuroendocrine cells and peptidergic innervation in human and rat prostate. Santamaría L; Ingelmo I; Alonso L; Pozuelo JM; Rodríguez R Adv Anat Embryol Cell Biol; 2007; 194():1-77. PubMed ID: 17595828 [No Abstract] [Full Text] [Related]
4. Re: expression of major heat shock proteins in prostate cancer: correlation with clinicopathological outcomes in patients undergoing radical prostatectomy. T. Kurahashi, H. Miyake, I. Hara and M. Fujisawa J Urol 2007; 177: 757-761. Vale S J Urol; 2007 Jul; 178(1):352-3. PubMed ID: 17507039 [No Abstract] [Full Text] [Related]
5. [Analysis of the metabolome suggests a major potential role of sarcosine in the progression of cancer of the prostate]. Darbon JM Bull Cancer; 2009 Apr; 96(4):355-6. PubMed ID: 19562840 [No Abstract] [Full Text] [Related]
6. Phage display selection of peptides that affect prostate carcinoma cells attachment and invasion. Romanov VI; Durand DB; Petrenko VA Prostate; 2001 Jun; 47(4):239-51. PubMed ID: 11398171 [TBL] [Abstract][Full Text] [Related]
7. Elevated expression of PCGEM1, a prostate-specific gene with cell growth-promoting function, is associated with high-risk prostate cancer patients. Petrovics G; Zhang W; Makarem M; Street JP; Connelly R; Sun L; Sesterhenn IA; Srikantan V; Moul JW; Srivastava S Oncogene; 2004 Jan; 23(2):605-11. PubMed ID: 14724589 [TBL] [Abstract][Full Text] [Related]
8. Effect of dutasteride on intraprostatic androgen levels in men with benign prostatic hyperplasia or prostate cancer. Rittmaster R; Hahn RG; Ray P; Shannon JB; Wurzel R Urology; 2008 Oct; 72(4):808-12. PubMed ID: 18718641 [TBL] [Abstract][Full Text] [Related]
9. The association of prostate stem cell antigen (PSCA) mRNA expression and subsequent prostate cancer risk in men with benign prostatic hyperplasia following transurethral resection of the prostate. Zhigang Z; Wenlu S Prostate; 2008 Feb; 68(2):190-9. PubMed ID: 18076024 [TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical expression of tumor antigens MAGE-A1, MAGE-A3/4, and NY-ESO-1 in cancerous and benign prostatic tissue. Hudolin T; Juretic A; Spagnoli GC; Pasini J; Bandic D; Heberer M; Kosicek M; Cacic M Prostate; 2006 Jan; 66(1):13-8. PubMed ID: 16114059 [TBL] [Abstract][Full Text] [Related]
11. The RASSF1A tumor suppressor gene is inactivated in prostate tumors and suppresses growth of prostate carcinoma cells. Kuzmin I; Gillespie JW; Protopopov A; Geil L; Dreijerink K; Yang Y; Vocke CD; Duh FM; Zabarovsky E; Minna JD; Rhim JS; Emmert-Buck MR; Linehan WM; Lerman MI Cancer Res; 2002 Jun; 62(12):3498-502. PubMed ID: 12067994 [TBL] [Abstract][Full Text] [Related]
12. Epigenetic heterogeneity of high-grade prostatic intraepithelial neoplasia: clues for clonal progression in prostate carcinogenesis. Henrique R; Jerónimo C; Teixeira MR; Hoque MO; Carvalho AL; Pais I; Ribeiro FR; Oliveira J; Lopes C; Sidransky D Mol Cancer Res; 2006 Jan; 4(1):1-8. PubMed ID: 16446401 [TBL] [Abstract][Full Text] [Related]
13. Emerging roles of chemokines in prostate cancer. Vindrieux D; Escobar P; Lazennec G Endocr Relat Cancer; 2009 Sep; 16(3):663-73. PubMed ID: 19556286 [TBL] [Abstract][Full Text] [Related]
14. Limiting the diagnosis of atypical small glandular proliferations in needle biopsies of the prostate by the use of immunohistochemistry. Helpap B; Köllermann J; Oehler U J Pathol; 2001 Mar; 193(3):350-3. PubMed ID: 11241415 [TBL] [Abstract][Full Text] [Related]
15. Expression of adrenomedullin and peptide amidation activity in human prostate cancer and in human prostate cancer cell lines. Rocchi P; Boudouresque F; Zamora AJ; Muracciole X; Lechevallier E; Martin PM; Ouafik L Cancer Res; 2001 Feb; 61(3):1196-206. PubMed ID: 11221851 [TBL] [Abstract][Full Text] [Related]
16. New concepts regarding the relationship of testosterone and prostate cancer. Morgentaler A Future Oncol; 2007 Apr; 3(2):123-6. PubMed ID: 17381410 [No Abstract] [Full Text] [Related]
17. The expression of neuropeptides in hyperplastic and malignant prostate tissue and its possible clinical implications. Yu DS; Hsieh DS; Chen HI; Chang SY J Urol; 2001 Sep; 166(3):871-5. PubMed ID: 11490236 [TBL] [Abstract][Full Text] [Related]
18. Unopposed c-MYC expression in benign prostatic epithelium causes a cancer phenotype. Williams K; Fernandez S; Stien X; Ishii K; Love HD; Lau YF; Roberts RL; Hayward SW Prostate; 2005 Jun; 63(4):369-84. PubMed ID: 15937962 [TBL] [Abstract][Full Text] [Related]
19. Editorial comment on: Shifting the paradigm of testosterone and prostate cancer: the saturation model and the limits of androgen-dependent growth. Sciarra A Eur Urol; 2009 Feb; 55(2):320-1. PubMed ID: 18838210 [No Abstract] [Full Text] [Related]
20. Neuroendocrine cells in human prostate over-express the anti-apoptosis protein survivin. Xing N; Qian J; Bostwick D; Bergstralh E; Young CY Prostate; 2001 Jun; 48(1):7-15. PubMed ID: 11391682 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]